Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 665 trials across Europe, recruiting first
Study of deucravacitinib compared to placebo in adolescents aged 12-17 years with moderate to severe plaque psoriasis
BelgiumStudy of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren's disease
BulgariaStudy of NVG-2089 given by intravenous infusion in patients with immune thrombocytopenia to evaluate safety and effectiveness
GreeceStudy of Mosunetuzumab Treatment in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis
ItalyStudy of momelotinib in patients with VEXAS syndrome and myelodysplastic syndrome who are dependent on or do not respond to steroid treatment
FranceStudy of felzartamab compared to placebo in adults with IgA nephropathy
BelgiumStudy of GHZ339 for treatment of moderate to severe atopic dermatitis
CzechiaStudy of sublingual immunotherapy with Dermatophagoides pteronyssinus and Dermatophagoides farinae allergen mix for patients with dust mite allergic rhinitis
SpainStudy of Ritlecitinib Combined with Narrow Band UVB Light Therapy Compared to Ritlecitinib Alone in Adults with Vitiligo
FranceStudy of Colchicine to Reduce Complications in People with Type 1 Diabetes and High Blood Sugar Variability
The NetherlandsStudy of IMMUNOSTEM gene therapy using modified stem cells for newly diagnosed patients with type 1 diabetes who still produce insulin
ItalyStudy of MTX-463 compared to placebo to assess its safety and effectiveness in adults with idiopathic pulmonary fibrosis
BelgiumThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
